Oncology
The CGTLive™ Oncology specialty topic page highlights the latest clinical care news related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for various cancers. It also houses video interviews with key opinion leaders in the field of oncology speaking to the related FDA actions, clinical guideline updates, and clinical trial findings in the field of gene and cell therapy for oncologic diseases.
Latest News
April 17th 2025
Renier Brentjens, MD, PhD, the chair of the department of medicine at Roswell Park Comprehensive Cancer Center, discussed his view on how the cell therapy field should proceed with regard to innovation.
%2520(2)%25201-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "Alfred L. Garfall, MD, MS, on Ide-Cel and Lenalidomide Maintenance in MM Following Suboptimal ASCT Response")
%2520(2)%25201-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "Nirav Shah, MD, MSHP, on Evaluating Zamto-Cel in R/R DLBCL")
%2520(2)%25201-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered-Recovered.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "Bhagirathbhai R. Dholaria, MD, on Evaluating P-BCMA-ALLO1 in R/R Myeloma")
Community Practice Connections™: Pre-Conference Workshop on Immune Cell-Based Therapy
View More
Go To PER in Chicago
May 30, 2025 - June 3, 2025
Register Now!
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD
View More
(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes
View More
More News
Evaluating Poseida Therapeutics' P-BCMA-ALLO1 With Optimized Lymphodepletion in R/R Myeloma
February 19th 2025Bhagirathbhai R. Dholaria, MD, an associate professor of medicine in malignant hematology & stem cell transplantation at Vanderbilt University Medical Center, discussed new results presented at Tandem 2025.
